Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates ("Broadwood†or "we†), which together own 30.2% of the outstanding common stock of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA), commented on the results of the Special Meeting of Shareholders (the "Special Meeting†) that was held earlier today in connection with the proposed acquisition of STAAR by Alcon Inc. ("Alcon†) (NYSE: ALC). Based on preliminary results, shareholders voted decisively to reject the. ...